EKKDA Announces Sales-Distribution Agreement with OCuSOFT Inc.

B2B Training: What’s the Most Effective Way of Learning?

B2B training, which is short for business-to-business training, is a popular and convenient type of training that enables entire companies to train their teams...

AlixPartners Forecasts: Household Products Could Cost U.S. Manufacturers and Consumers 15% More This Year Due to Resin Shortage

While companies can’t control the market forces at play, they can take action to mitigate the risk and impact of supply chain disruption.

EKKDA Research, LLC, an ophthalmic-focused research and development company based in Kingsland, Texas is pleased to announce a sales-distribution agreement has been reached with OCuSOFT Inc. Stacy Foster, EKKDA’s Chairman and the former Chief Business Officer for OCuSOFT®, made the announcement today.

According to Mr. Foster, given the established ophthalmic relationships both in ophthalmology and optometry, EKKDA’s research projects will be focused primarily on eye care.  There are, however, other opportunities in various fields including dermatology, urology, and neurology to name a few. The greater Austin area has become a hotbed of innovation in both technology and medicine according to Mr. Foster.  He also states, “Some of the early projects EKKDA is working on will be quicker to market so having a sales, marketing, and distribution partner like OCuSOFT® is a real plus. They have the respect of the eye care community with a long track record of service. I should know I spent 11 years with the company”.  Mr. Foster goes on to say that further announcements relating to projects underway will be made in due course.

spot_img

DON'T MISS

Mediclinic Appoints 2 New Independent Non-Executive Directors

Natalia Barsegiyan and Zarina Bassa will bring significant and diverse skills and experience, complementing those of existing Board members. I am confident they will both be great additions to our Board of Directors.”

Asensus Surgical Appoints Two New Board Members

Asensus Surgical, Inc. (NYSE American: ASXC), a medical device company that is digitizing the interface between the surgeon and the patient to pioneer a new era of Performance-Guided Surgery™, today announced the expansion of its Board of Directors, appointing...

Our Sister Publication: Biotechnology News Magazine

Subscribe to Medical Device News Magazine here.